PECAM1 and renal cell adenocarcinoma: Indeed, Bauman and colleagues [53] showed that within RCC morphotypes, the CD105/CD31 ratio, used to measure neovascularity, was significantly lower in papillary tumors (p = 0.05) when compared to clear cell samples.